
Natco Pharma launches higher strength anti-cancer generic drug in U.S.
The Hindu
Natco Pharma on Friday said marketing partner Breckenridge Pharmaceutical Inc. has launched 10 mg strength of Everolimus Tablets (generic for Afinitor) in the US market. The drug is used in the treatm
Natco Pharma on Friday said marketing partner Breckenridge Pharmaceutical Inc. has launched 10 mg strength of Everolimus Tablets (generic for Afinitor) in the US market.
The drug is used in the treatment of certain cancer. USFDA had previously granted final approval for this ANDA.
The 10mg strength of Afinitor had generated annual sales of $392 million during the twelve months ending July 2021, it said citing industry sales data.

The draft policy for “Responsible Digital Use Among Students”, released on Monday by the Department of Health and Family Welfare, has recommended that parents set structured routines with clear screen-time rules and prioritise privacy, safety, and open conversation with children on digital well-being.












